One-Year Interim Analysis of Health-Related Quality of Life in RRMS Patients Treated With Alemtuzumab in a Real-world Clinical Setting (LemQoL Study)

Wijmeersch B Van, T Harrower, J Hobart, R Kizlaitiene, GA Marfia, F Patti, OR Pearson, Pesch V Van, P Vanderdonckt, L Vecsei, S Shor, A Achiron

Research output: Contribution to conferenceConference paper (not formally published)peer-review

Original languageEnglish
DOIs
Publication statusPublished - May 2020

Cite this